Searched for
CLINICAL TRIALS ACCESS
The man behind Lord’s Mark: Dr. Sachidanand Upadhyay features in TIME Magazine for the third consecutive yearDr. Sachidanand Upadhyay has gained recognition from TIME Magazine for his remarkable contributions to technology and innovation. Lord’s Ma...
His grandfather died of pancreatic cancer: This Hyderabad startup founder is using AI to develop a personalised cancer vaccinesHyderabad-based biotech startup PopVax, founded by Soham Sankaran, is developing AI-powered personalised cancer vaccines using mRNA technol...
Wockhardt expands novel antibiotic Miqnaf's access; Q2 revenue rises 24%Wockhardt has expanded its marketing access for Miqnaf in India following the removal of a supply condition. The company's biotechnology se...
Kirana stores make room for new generation FMCG brands as they muscle past legacy giantsIndia's kirana market has seen new-age consumer brands expand their market share to nearly 22%. This increase has impacted the dominance of...
AI halves drug discovery times, but =trial bottleneck remains a costly realityNovo Nordisk, Sanofi and Dr Reddy’s Laboratories are among the companies exploring applications ranging from drug discovery to laboratory a...
Pathos AI teams up with Bristol Myers and Tempus AI to advance drug developmentPathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence too...
Arizona University cancer researcher dies of the disease she fought to cure; her final wish was to raise $1.35 million for cancer researchDr. Rachna Shroff, a revered cancer researcher, sadly succumbed to terminal adenocarcinoma at the age of 47. Her condition emerged from a m...
Our central mission must be patient-centric innovation: JP NaddaJ P Nadda urges industry to take discoveries ‘from bench to bedside’ as the FICCI–Lilly Bharat Life Sciences Award backs its inaugural coho...
Indian companies must invest in R&D, move from generics to innovation-led industry: Pharma leadersIndian pharmaceutical leaders emphasize the need for investment in innovation to transition from generics to innovative products. They high...
‘India’s biotech ecosystem holds tremendous promise’: Eli Lilly CEOEli Lilly has experienced significant growth, reaching a market capitalization over $1 trillion. The company aims to maintain its leadershi...
Where Does China Fit in Your Company’s Innovation Strategy?For decades, multinationals treated China primarily as either a vast growth market or a rising competitive threat. But as growth slows, com...
Rs 78,400 vs Rs 7,750 medicine: Novartis, Eli Lilly oppose bid to cut breast cancer drug prices in IndiaNovartis and Eli Lilly have opposed a Kerala High Court petition seeking government intervention to make two breast cancer drugs cheaper, d...
Lord’s Mark advances AI breast cancer screening towards clinical trialsIn a groundbreaking collaboration with C-MET, Lord's Mark Industries Limited is making strides in breast cancer screening technology. Utili...
Psychology explains how mindfulness calms racing thoughts, lowers stress, and restores sleep better than basic sleep tipsEngaging in mindfulness meditation presents a powerful strategy to alleviate nighttime anxiety. This technique not only soothes mental turm...
India emerging as a top destination for clinical trials, says reportIndia's regulatory reforms since 2013 and the New Drugs and Clinical Trial Rules of 2019 have made it an attractive destination for clinica...
India emerging as favourable destination to conduct global clinical trials: ReportThe joint report by the USA India Chamber of Commerce & PwC India titled, “Clinical Trial opportunities in India” which will be released at...
Aid groups plan to widen Covid-19 trial baseA global coalition of aid organisations, government agencies and academic institutions will facilitate the clinical trials of Covid-19 drug...